Stock AYRTN AYRTON DRUGS MANUFACTURING COMPANY LTD.
Add to a list
To use this feature you must be a member
Log inSign up

News Ayrton Drugs Manufacturing Company Ltd.

Equities

AYRTN

GH0000000672

End-of-day quote Ghana S.E.
Other stock markets
- GHS - Intraday chart for Ayrton Drugs Manufacturing Company Ltd.
2019 Ayrton Drug Manufacturing Ltd Reports Earnings Results for the First Quarter Ended September 30, 2019 CI
2019 Ayrton Drug Manufacturing Ltd Reports Earnings Results for the Full Year Ended June 30, 2019 CI

Summary

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
Ayrton Drug Manufacturing Ltd Reports Earnings Results for the First Quarter Ended September 30, 2019
CI
Ayrton Drug Manufacturing Ltd Reports Earnings Results for the Full Year Ended June 30, 2019
CI
Ayrton Drug Manufacturing Ltd Reports Earnings Results for the Half Year Ended December 31, 2018
CI
Ayrton Drugs Manufacturing Company Ltd. Reports Earnings Results for the First Quarter Ended September 30, 2018
CI
Ayrton Drug Manufacturing Ltd Announces Unaudited Earnings Results for the Period Ending June 30, 2018
CI
Ayrton Drugs Manufacturing Company Ltd. Reports Unaudited Financial Results for the Third Quarter Ended March 31, 2018
CI
Ayrton Drug Manufacturing Ltd. Announces Unaudited Earnings Results for the First Quarter Ended Sep. 30, 2017
CI
Ayrton Drug Manufacturing Ltd Announces Unaudited Earnings Results for the Third Quarter Ended March 31, 2017
CI
Ayrton Drugs Manufacturing Limited Reports Unaudited Earnings Results for the Half Year Ended December 31, 2016
CI
Dannex Limited completed the acquisition of 53.47% stake in Ayrton Drugs Manufacturing Company Ltd. from Adcock Ingram Holdings Limited.
CI
Ayrton Drugs Manufacturing Limited Reports Earnings Results for the Year Ended June 30, 2016
CI
Dannex Plans To Acquire 53.47% Stake In Ayrton
CI
Dannex Limited entered into a sale of shares agreement to acquire 53.47% stake in Ayrton Drugs Manufacturing Company Ltd. from Adcock Ingram Holdings Limited.
CI
Ayrton Drugs Manufacturing Limited Announces Unaudited Earnings Results for the Third Quarter Ended March 31, 2016
CI
Adcock Ingram To Divest Ayrton Drugs And Indian Sales & Marketing Unit
CI
AYRTN Announces the Resignation of Leslie Kofi Amegashie from the Board
CI
Ayrton Drugs Manufacturing Company Ltd. Reports Audited Financial Results for the Nine Months Ended June 30, 2014
CI
Ayrton Drugs Manufacturing Company Ltd. Announces Executive Changes, Effective December 1, 2012
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. AYRTN Stock
  4. News Ayrton Drugs Manufacturing Company Ltd.